Medical Monitor, MD
Precision BioSciences, Inc. · BioMarin Pharmaceutical · Capsida Biotherapeutics, Inc.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
77
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers
0
PubMed author-name match
Trials
Studies that name Medical Monitor, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:34 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT06680232 · Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis BPrecision BioSciences, Inc. · recruiting · HEPATITIS B CHRONIC · study director
- Ph3NCT06224907 · Phase 3 Study for Efficacy and Safety Outcomes Data in Japanese Patients With Severe Hemophilia ABioMarin Pharmaceutical · active not recruiting · Hemophilia A · study director
- N/ANCT05462054 · Natural History Study in Pediatric Patients with STXBP1 Encephalopathy with EpilepsyCapsida Biotherapeutics, Inc. · withdrawn · STXBP1 Encephalopathy with Epilepsy · study director
- Ph2NCT04826172 · Exploratory Study on the Safety, Tolerability, and Pharmacodynamics of IMB-1018972 in Subjects With Angina Due to Obstructive Coronary Artery Disease (IMPROVE-Ischemia)Imbria Pharmaceuticals, Inc. · completed · Ischemia, Coronary Artery Disease · study chair
- Ph2NCT04785365 · Long-Term Follow-Up Study of Patients Receiving ATL001Achilles Therapeutics UK Limited · terminated · Melanoma, Advanced Non Small Cell Lung Cancer · study director
- Ph1/Ph2NCT04684940 · Safety, Tolerability, and Efficacy Study of Valoctocogene Roxaparvovec in Hemophilia A With Active or Prior InhibitorsBioMarin Pharmaceutical · completed · Hemophilia A With Inhibitor, Hemophilia A With Anti Factor VIII · study director
- N/ANCT04628871 · Long Term Follow-up (LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIXSangamo Therapeutics · terminated · Hemophilia B, Mucopolysaccharidosis I, Mucopolysaccharidosis II · study director
- Ph2NCT04418427 · ADVM-022 Intravitreal Gene Therapy for DMEAdverum Biotechnologies, Inc. · completed · Diabetic Macular Edema, Diabetic Retinopathy · study chair
- Ph3NCT04323098 · Study to Evaluate the Efficacy and Safety of Valoctocogene Roxaparvovec, With Prophylactic Steroids in Hemophilia ABioMarin Pharmaceutical · completed · Hemophilia A · study director
- Ph1/Ph2NCT04032847 · ATL001 in Patients With Advanced Unresectable or Metastatic NSCLCAchilles Therapeutics UK Limited · terminated · Advanced Non Small Cell Lung Cancer · study director
- Ph1/Ph2NCT03997474 · ATL001 in Patients With Metastatic or Recurrent MelanomaAchilles Therapeutics UK Limited · terminated · Melanoma · study director
- Ph2NCT03784287 · A Treatment Extension Study of Mucopolysaccharidosis Type IIIBAllievex Corporation · unknown · Mucopolysaccharidosis Type IIIB, MPS III B · study director
- Ph3NCT03370913 · Single-Arm Study To Evaluate The Efficacy and Safety of Valoctocogene Roxaparvovec in Hemophilia A Patients (BMN 270-301)BioMarin Pharmaceutical · completed · Hemophilia A · study director
- Ph1/Ph2NCT02485899 · An Extension Study to Evaluate the Long-Term Efficacy and Safety of BMN 190 in Patients With CLN2 DiseaseBioMarin Pharmaceutical · completed · Jansky-Bielschowsky Disease, Batten Disease, Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 · study director
- Ph2NCT02287922 · A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid ArthritisAblynx, a Sanofi company · completed · Rheumatoid Arthritis · study director
- N/ANCT02221362 · A Prospective, Noninterventional, Observational Study of Late-Onset Pompe DiseaseBioMarin Pharmaceutical · terminated · Late-onset Pompe Patients Untreated or Treated With rhGAA · study director
- N/ANCT02191917 · A Study of Respiratory Muscle Strength in Patients With Late-onset Pompe Disease (LOPD)BioMarin Pharmaceutical · terminated · Late-onset Pompe Disease · study director
- Ph1/Ph2NCT00541866 · Safety and Tolerability Study of Voreloxin and Cytarabine Combination in Acute Myeloid Leukemia in HumansSunesis Pharmaceuticals · completed · Acute Myeloid Leukemia · study director
- Ph2NCT00518271 · Study Comparing Standard Dose and Reduced Dose Tacrolimus + Sirolimus + Corticosteroids in Renal Allograft RecipientsWyeth is now a wholly owned subsidiary of Pfizer · completed · Kidney Transplantation · study director
- Ph3NCT00428064 · Study Evaluating Sirolimus and Cyclosporine in Kidney Transplant RecipientsWyeth is now a wholly owned subsidiary of Pfizer · completed · Renal Transplantation · study director
- Ph2NCT00408603 · Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian CancerSunesis Pharmaceuticals · completed · Epithelial Ovarian Cancer · study director
- Ph3NCT00399542 · Efficacy and Safety of Lubiprostone in Patients With Irritable Bowel Syndrome With ConstipationSucampo Pharma Americas, LLC · completed · Irritable Bowel Syndrome, Constipation · study director
- Ph2NCT00396266 · AMD3100 (Plerixafor) Given to NHL and MM Patients to Increase the Number of PBSCs When Given a Mobilizing Regimen of G-CSFGenzyme, a Sanofi Company · completed · Multiple Myeloma, Lymphoma, Non-Hodgkin · study director
- Ph1NCT00345189 · Study of Oral CNF2024 (BIIB021) in Advanced Solid TumorsBiogen · completed · Tumors, Lymphoma · study director
- Ph1/Ph2NCT00257387 · Study Evaluating Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese Kidney TransplantsWyeth is now a wholly owned subsidiary of Pfizer · completed · Kidney Transplant · study director
- Ph3NCT00248313 · Study Comparing Cyclosporin Dose Reduction With Cyclosporin Elimination in Kidney Transplant Recipients Taking SirolimusWyeth is now a wholly owned subsidiary of Pfizer · completed · Kidney Disease · study director
- Ph3NCT00245973 · Study Evaluating Bifeprunox in Bipolar DepressionWyeth is now a wholly owned subsidiary of Pfizer · completed · Depression Bipolar · study director
- N/ANCT00241397 · Study Evaluating Rhapsody Registry in Patients With Depression and AnxietyWyeth is now a wholly owned subsidiary of Pfizer · completed · Pain, Depression, Anxiety Disorder · study director
- Ph3NCT00195273 · Study Evaluating Sirolimus in Kidney Transplant RecipientsWyeth is now a wholly owned subsidiary of Pfizer · completed · Graft vs Host Disease, Kidney Transplantation · study director
- Ph1NCT00195312 · Study Evaluating Vaccine in Adults With HIVWyeth is now a wholly owned subsidiary of Pfizer · terminated · HIV Infections · study director
- Ph3NCT00161681 · Study Evaluating Levonorgestrel/Ethinyl Estradiol (LNG/EE) in PMSWyeth is now a wholly owned subsidiary of Pfizer · completed · Premenstrual Syndrome · study director
- Ph3NCT00134459 · Study Evaluating Bifeprunox in Bipolar DepressionWyeth is now a wholly owned subsidiary of Pfizer · completed · Bipolar Disorder · study director
- Ph3NCT00128934 · Study Evaluating Combination of Levonorgestrel (LNG) and Ethinyl Estradiol (EE) in Premenstrual Dysphoric DisorderWyeth is now a wholly owned subsidiary of Pfizer · completed · Menstruation Disturbances, Premenstrual Syndrome · study director
- Ph2NCT00124891 · Study Evaluating GAP-486 in Non-sustained Ventricular TachycardiaWyeth is now a wholly owned subsidiary of Pfizer · terminated · Arrhythmias · study director
- Ph2NCT00116103 · A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent AsthmaAstellas Pharma Inc · completed · Asthma · study director
- Ph1/Ph2NCT00104078 · Study Evaluating MYO-029 in Adult Muscular DystrophyWyeth is now a wholly owned subsidiary of Pfizer · completed · Becker Muscular Dystrophy, Facioscapulohumeral Muscular Dystrophy, Limb-Girdle Muscular Dystrophy · study director
- Ph2NCT00095342 · Study Evaluating TMI-005 in Active Rheumatoid ArthritisWyeth is now a wholly owned subsidiary of Pfizer · completed · Rheumatoid Arthritis · study director
- Ph3NCT00093210 · Study Evaluating of Recombinant Human Factor IX (BeneFIX) and a New Formulation of BeneFIX (rFIX-R) in Moderate to Severe Hemophilia BWyeth is now a wholly owned subsidiary of Pfizer · completed · Hemophilia B · study director
- Ph3NCT00093171 · Study Evaluating rFIX; BeneFIX® in Hemophilia BWyeth is now a wholly owned subsidiary of Pfizer · completed · Hemophilia B · study director
- Ph4NCT00092976 · Study Evaluating ReFacto® in Hemophilia A Undergoing Major SurgeryWyeth is now a wholly owned subsidiary of Pfizer · completed · Hemophilia A · study director
- Ph3NCT00092911 · Study Evaluating DVS-233 SR in Adult Outpatients With Major Depressive DisorderWyeth is now a wholly owned subsidiary of Pfizer · completed · Depression, Depressive Disorder, Major Depressive Disorder · study director
- Ph3NCT00090649 · Study Evaluating DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive DisorderWyeth is now a wholly owned subsidiary of Pfizer · completed · Major Depressive Disorder · study director
- Ph1NCT00088647 · Study Evaluating MST-997 in Advanced Malignant Solid TumorsWyeth is now a wholly owned subsidiary of Pfizer · terminated · Neoplasms · study director
- Ph3NCT00087737 · Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive DisorderWyeth is now a wholly owned subsidiary of Pfizer · completed · Major Depressive Disorder · study director
- Ph3NCT00081744 · Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized SubjectsWyeth is now a wholly owned subsidiary of Pfizer · completed · Gram-Positive Bacterial Infections, Cross Infection · study director
- Ph3NCT00081575 · Study Comparing Tigecycline vs. Levofloxacin in Subjects Hospitalized With Community-Acquired PneumoniaWyeth is now a wholly owned subsidiary of Pfizer · completed · Community-Acquired Infections, Bacterial Pneumonia, Cross Infection · study director
- Ph3NCT00079989 · Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative OrganismsWyeth is now a wholly owned subsidiary of Pfizer · completed · Gram-Negative Bacterial Infections · study director
- Ph3NCT00079976 · Study Evaluating Tigecycline in Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA)Wyeth is now a wholly owned subsidiary of Pfizer · completed · Gram-Positive Bacterial Infections, Staphylococcus Infections, Vancomycin Resistance · study director
- Ph3NCT00079885 · Study Evaluating Tigecycline vs Levofloxacin in Hospitalized With Community-Acquired PneumoniaWyeth is now a wholly owned subsidiary of Pfizer · completed · Community Acquired Pneumonia, Bacterial Pneumonia, Cross Infection · study director
- Ph2NCT00076206 · Study Evaluating CCI-779 in Active Rheumatoid Arthritis on Concomitant Methotrexate TherapyWyeth is now a wholly owned subsidiary of Pfizer · terminated · Rheumatoid Arthritis · study director
- Ph3NCT00075257 · Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive DisorderWyeth is now a wholly owned subsidiary of Pfizer · completed · Major Depressive Disorder · study director
- Ph3NCT00073762 · Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive DisorderWyeth is now a wholly owned subsidiary of Pfizer · completed · Major Depressive Disorder · study director
- Ph2NCT00073034 · Study Evaluating EAA-090 in Adult Outpatients With Neuropathic Pain Associated With Diabetic NeuropathyWyeth is now a wholly owned subsidiary of Pfizer · terminated · Diabetes Mellitus, Diabetic Neuropathy, Painful · study director
- Ph3NCT00072774 · Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive DisorderWyeth is now a wholly owned subsidiary of Pfizer · completed · Major Depressive Disorder · study director
- Ph2NCT00072748 · Study Evaluating EKB-569 in Advanced Colorectal CancerWyeth is now a wholly owned subsidiary of Pfizer · completed · Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms · study director
- Ph2NCT00067548 · Study Evaluating EKB-569 in Advanced Non-Small Cell Lung CancerWyeth is now a wholly owned subsidiary of Pfizer · completed · Non-Small-Cell Lung Carcinoma, Carcinoma, Non-Small Cell Lung, Lung Neoplasms · study director
- Ph2NCT00063869 · Study Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary FibrosisWyeth is now a wholly owned subsidiary of Pfizer · completed · Pulmonary Fibrosis · study director
- Ph2NCT00063427 · Study Evaluating MAC-321 in Colorectal CancerWyeth is now a wholly owned subsidiary of Pfizer · completed · Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms · study director
- Ph3NCT00063206 · Study Evaluating DVS-233 in Adult Outpatients With Major Depressive DisorderWyeth is now a wholly owned subsidiary of Pfizer · completed · Major Depressive Disorder · study director
- Ph2NCT00063219 · Study Evaluating MAC-321 in Non-small Cell Lung Cancer Refractory to Platinum-based TherapyWyeth is now a wholly owned subsidiary of Pfizer · completed · Carcinoma, Non-Small-Cell Lung, Lung Neoplasms · study director
- Ph4NCT00046020 · Study Evaluating Venlafaxine ER in Recurrent DepressionWyeth is now a wholly owned subsidiary of Pfizer · completed · Depressive Disorder, Major, Recurrence · study director
- Ph4NCT00044928 · Study Evaluating Zosyn in Hospitalized Patients With Intra-abdominal InfectionWyeth is now a wholly owned subsidiary of Pfizer · completed · Bacterial Infections · study director
- Ph3NCT00044759 · Study Comparing the Safety and Efficacy of Piperacillin/Tazobactam to Cefepime in Patients With Hematologic Malignancy or LymphomaWyeth is now a wholly owned subsidiary of Pfizer · completed · Hematologic Neoplasms · study director
- Ph4NCT00044720 · Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant RecipientsWyeth is now a wholly owned subsidiary of Pfizer · completed · Chronic Kidney Failure, Graft vs Host Disease, Kidney Transplantation · study director
- Ph2NCT00044733 · Study Evaluating Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia After Stem Cell TransplantWyeth is now a wholly owned subsidiary of Pfizer · completed · Acute Myelogenous Leukemia · study director
- Ph4NCT00044746 · Study Evaluating the Safety and Efficacy of Piperacillin/Tazobactam and Ampicillin/Sulbactam in Patients With Diabetic Foot InfectionsWyeth is now a wholly owned subsidiary of Pfizer · completed · Diabetes Mellitus, Diabetic Foot · study director
- Ph3NCT00044772 · Study Evaluating Venlafaxine ER in Patients With Panic DisorderWyeth is now a wholly owned subsidiary of Pfizer · completed · Panic Disorder · study director
- Ph3NCT00040495 · Study Evaluating Pantoprazole in Peptic Ulcer HemorrhageWyeth is now a wholly owned subsidiary of Pfizer · completed · Peptic Ulcer Hemorrhage · study director
- Ph3NCT00038935 · Study Evaluating BDDRFVIII and ReFacto AF in Hemophilia AWyeth is now a wholly owned subsidiary of Pfizer · completed · Hemophilia A · study director
- Ph3NCT00038948 · Study Comparing Conversion to Sirolimus vs. Continued Use of Calcineurin Inhibitors in Kidney Transplant RecipientsWyeth is now a wholly owned subsidiary of Pfizer · completed · Renal Transplantation · study director
- N/ANCT00038909 · Study Evaluating ReFacto in Hemophilia AWyeth is now a wholly owned subsidiary of Pfizer · completed · Hemophilia A · study director
- Ph1NCT00038922 · Study Evaluating rhIL-11 in Left-Sided Ulcerative ColitisWyeth is now a wholly owned subsidiary of Pfizer · terminated · Ulcerative Colitis, Inflammatory Bowel Disease · study director
- Ph3NCT00037531 · Study Evaluating Sirolimus (Rapamune™) in Solid Organ Transplant RecipientsWyeth is now a wholly owned subsidiary of Pfizer · completed · Graft vs Host Disease, Kidney Transplantation · study director
- Ph2NCT00037570 · Study Evaluating Pantoprazole in Peptic Ulcer HemorrhageWyeth is now a wholly owned subsidiary of Pfizer · completed · Peptic Ulcer Hemorrhage · study director
- Ph3NCT00037544 · Study Evaluating ReFacto AF in Severe Hemophilia AWyeth is now a wholly owned subsidiary of Pfizer · completed · Hemophilia A · study director
- Ph2NCT00037596 · Study Evaluating Gemtuzumab Ozogamicin in Acute Myeloid LeukemiaWyeth is now a wholly owned subsidiary of Pfizer · completed · Acute Myeloid Leukemia · study director
- Ph3NCT00037557 · Study Evaluating rFIX; BeneFIX in Severe Hemophilia BWyeth is now a wholly owned subsidiary of Pfizer · completed · Hemophilia B · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:34 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.